adult oligodendroglial tumors
Showing 1 - 25 of >10,000
Advanced Solid Tumors With MAPK Pathway Mutations Trial in Nedlands (D3S-002)
Not yet recruiting
- Advanced Solid Tumors With MAPK Pathway Mutations
-
Nedlands, Western Australia, AustraliaD3 Bio Investigative Site
May 24, 2023
Gastrointestinal Tumors Trial in Beijing (AZD6422 CLDN18.2 CAR-T product)
Not yet recruiting
- Gastrointestinal Tumors
- AZD6422 CLDN18.2 CAR-T product
-
Beijing, ChinaBeijing Cancer Hospital
Aug 1, 2023
Solid Tumors With HRAS Alterations, Non Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC) Trial (KO-2806, Cabozantinib)
Not yet recruiting
- Solid Tumors With HRAS Alterations
- +4 more
- (no location specified)
Aug 30, 2023
Pediatric Brain Tumor Trial in Boston (HIIT Exercise Program, Control Group)
Not yet recruiting
- Pediatric Brain Tumor
- HIIT Exercise Program
- Control Group
-
Boston, MassachusettsDana Farber Cancer Institute
Feb 13, 2023
GT316,Solid Tumors,Adult Trial in Zhengzhou (GT316)
Recruiting
- GT316,Solid Tumors,Adult
- GT316
-
Zhengzhou, Henan, ChinaThe First Affiliated Hospital of Zhengzhou University
Oct 16, 2023
Advanced Solid Tumors Trial in Houston (PUR001)
Recruiting
- Advanced Solid Tumors
-
Houston, TexasThe University of Texas MD Anderson Cancer Center
Jan 18, 2023
Clear Cell Renal Cell Carcinoma, Cervical Carcinoma, Esophageal Carcinoma Trial in Nashville (CTX131)
Recruiting
- Clear Cell Renal Cell Carcinoma
- +4 more
- CTX131
-
Nashville, TennesseeResearch Site 1
Mar 21, 2023
Solid Tumors, Adult Trial in Xuzhou (TIL injection)
Recruiting
- Solid Tumors, Adult
- TIL injection
-
Xuzhou, Jiangsu, ChinaThe Affiliated Hospital Of Xuzhou Medical University
Oct 12, 2023
Solid Tumor, Adult Trial in Beijing (TY-2699a)
Not yet recruiting
- Solid Tumor, Adult
-
Beijing, Beijing, ChinaNational Cancer Center/Cancer Hospital, Chinese Academy of Medic
May 18, 2023
Solid Tumors, ER+ Breast Cancer, Triple Negative Breast Cancer, TNBC Trial (JAB-2485 (Aurora A inhibitor))
Not yet recruiting
- Solid Tumors
- +4 more
- JAB-2485 (Aurora A inhibitor)
- (no location specified)
Aug 4, 2022
Anaplastic Large Cell Lymphoma, ALK-Positive, Inflammatory Myofibroblastic Tumor, Other Solid Tumor Trial in Utrecht
Recruiting
- Anaplastic Large Cell Lymphoma, ALK-Positive
- +2 more
-
Paris, France
- +1 more
Sep 27, 2022
NSCLC, Head and Neck Squamous Cell Carcinoma, Colorectal Carcinoma Trial in Duarte (Autologous, engineered T Cells targeting
Not yet recruiting
- Non-small Cell Lung Cancer
- +5 more
- Autologous, engineered T Cells targeting TP53 R175H
-
Duarte, CaliforniaCity of Hope
May 17, 2023
Solid Tumors, Adult Trial (tumor treatment vaccine injection)
Not yet recruiting
- Solid Tumors, Adult
- tumor treatment vaccine injection
- (no location specified)
Feb 16, 2023
Solid Tumor, Adult Trial in Shanghai (Tislelizumab, Lenvatinib, Cryoablation)
Recruiting
- Solid Tumor, Adult
- Tislelizumab
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Sep 13, 2023
Benign Centrally-Located Intracranial Tumors Trial in Washington, Miami (ExAblate 4000 System)
Recruiting
- Benign Centrally-Located Intracranial Tumors
- ExAblate 4000 System
-
Washington, District of Columbia
- +1 more
Aug 16, 2022
Adult Trial in Zhengzhou (GT101)
Recruiting
- Adult
- GT101
-
Zhengzhou, Henan, ChinaThe First Affiliated Hospital of Zhengzhou University
Oct 11, 2023
Advanced Solid Tumor Trial in Kuching (BL0020)
Not yet recruiting
- Advanced Solid Tumor
-
Kuching, MalaysiaSarawak General Hospital
May 24, 2023
Solid Tumor Trial (JAB-BX102 (anti-CD73 mAb), pembrolizumab (anti-PD-1 mAb))
Not yet recruiting
- Solid Tumor
- JAB-BX102 (anti-CD73 monoclonal antibody)
- pembrolizumab (anti-PD-1 monoclonal antibody)
- (no location specified)
Jul 19, 2022